NEDD9 and cancer: Because HEF1 is considered to act during FA turnover (3, 4, 27, –, 29), cancer cell migration activity was monitored using HeLa cells lacking endogenous HEF1 but stably expressing exogenous HEF1 WT or its S780A/T804A mutant, as described in Fig. 5C.